Medicaid Drug Formulary Ideas Floated, But US Manufacturers Are Skeptical

Medicaid formularies capable of excluding drugs to drive better rebates could replace the existing drug rebate program, lobbyists suggest, but US manufacturers worry that lawmakers will be leery of losing statutory-based rebates.